Valetudo Therapeutics LLC sold LIMN
June 24, 2026 · Form 4 insider transaction
Valetudo Therapeutics LLC sold 4,373,603 shares of Liminatus Pharma, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4, filed 12 days after the transaction.
Footnotes
The reported transaction involves a transfer of securities for which no payment of consideration was received.; Consists of 1,795,803 shares of common stock held of record by Valetudo Therapeutics LLC ("Valetudo"). On June 24, 2026, Valetudo transferred 4,373,603 shares of common stock to Ewon Comfortech Co., Ltd and retains voting power over such shares pursuant to a voting agreement. Mr. Chris Kim is the CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner of, the shares held by Valetudo. The business address of Valetudo is 2251 Stern Goodman Street, Suite E, Fullerton, California 92833. Mr. Kim disclaims any beneficial ownership of any shares held by Valetudo except to the extent of his ultimate pecuniary interest therein.